Evidence map›Paper›PMID 27659010›Full record

ArticleJournal of immunological methods2016

Detection of herpes simplex virus type 2 (HSV-2) -specific cell-mediated immune responses in guinea pigs during latent HSV-2 genital infection.

Clarice L Perry, Brianne N Banasik, Summer R Gorder, Jingya Xia, Sarah Auclair, Nigel Bourne, Gregg N Milligan

Open access · greenAbstract read
In one paragraph

Article in Journal of immunological methods, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Clarice L PerryDepartment of Pediatrics, University of Texas Medical Branch, Galveston, TX, United States.
Brianne N BanasikDepartment of Pediatrics, University of Texas Medical Branch, Galveston, TX, United States.
Summer R GorderDepartment of Pediatrics, University of Texas Medical Branch, Galveston, TX, United States.
Jingya XiaDepartment of Pediatrics, University of Texas Medical Branch, Galveston, TX, United States; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, United States.
Sarah AuclairDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, United States.
Nigel BourneDepartment of Pediatrics, University of Texas Medical Branch, Galveston, TX, United States; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, United States; Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, TX, United States.
Gregg N MilliganDepartment of Pediatrics, University of Texas Medical Branch, Galveston, TX, United States; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, United States; Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, TX, United States. Electronic address: gnmillig@utmb.edu.
The University of Texas Medical Branch at Galveston · US

Funding

Induction, maintenance, and function of genital tract-resident CD8+ T cellsR01AI107784 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI MILLIGAN, GREGG N. · 2015 to 2019
$1.7M
Therapeutic immunization to impact HSV-2 latency and associated pathogenesisR21AI105962 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI BOURNE, NIGEL · 2013 to 2014
$414k
NIAID NIH HHS R01 AI107784NIAID NIH HHS R21 AI105962
6 · The paper itself

Abstract

Genital infections with herpes simplex virus type 2 (HSV-2) are a source of considerable morbidity and are a health concern for newborns exposed to virus during vaginal delivery. Additionally, HSV-2 infection diminishes the integrity of the vaginal epithelium resulting in increased susceptibility of individuals to infection with other sexually transmitted pathogens. Understanding immune protection against HSV-2 primary infection and immune modulation of virus shedding events following reactivation of the virus from latency is important for the development of effective prophylactic and therapeutic vaccines. Although the murine model of HSV-2 infection is useful for understanding immunity following immunization, it is limited by the lack of spontaneous reactivation of HSV-2 from latency. Genital infection of guinea pigs with HSV-2 accurately models the disease of humans including the spontaneous reactivation of HSV-2 from latency and provides a unique opportunity to examine virus-host interactions during latency. Although the guinea pig represents an accurate model of many human infections, relatively few reagents are available to study the immunological response to infection. To analyze the cell-mediated immune response of guinea pigs at extended periods of time after establishment of HSV-2 latency, we have modified flow-cytometry based proliferation assays and IFN-γ ELISPOT assays to detect and quantify HSV-specific cell-mediated responses during latent infection of guinea pigs. Here we demonstrate that a combination of proliferation and ELISPOT assays can be used to quantify and characterize effecter function of virus-specific immune memory responses during HSV-latency.

Indexed as

Enzyme-Linked Immunospot AssayImmunity, CellularLymphocyte ActivationVirus LatencyAnimalsCell ProliferationCells, CulturedDisease Models, AnimalFemaleFlow CytometryGuinea PigsHerpes GenitalisHerpesvirus 2, HumanHost-Pathogen InteractionsInterferon-gammaTime FactorsInterferon-gammaCell-mediated immunityGenital tractGuinea pigHSV-2 latencyIFN-gammaT cell proliferation

Identifiers

PMID27659010
PMCPMC5125880
OpenAlexW2522041197

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.